Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (MMC-1)
|ClinicalTrials.gov Identifier: NCT01536899|
Recruitment Status : Completed
First Posted : February 22, 2012
Last Update Posted : April 5, 2018
The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.
Several alternative hypotheses will be evaluated in the proposed project:
- healthier patients may self-select marijuana use;
- marijuana use may be associated with consequences that create barriers to seeking healthcare;
- marijuana use may have medicinal value that reduces the need for such care.
|Condition or disease|
|HIV Positive Marijuana Smoking|
The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year.
The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.
We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.
|Study Type :||Observational|
|Actual Enrollment :||119 participants|
|Official Title:||Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study|
|Study Start Date :||February 2012|
|Actual Primary Completion Date :||June 2017|
|Actual Study Completion Date :||June 2017|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01536899
|United States, Michigan|
|Wayne State University (HIV clinic, Tolan Park Medical Buiding)|
|Detroit, Michigan, United States, 48201|
|Principal Investigator:||Mark Greenwald, PhD||Wayne State University|